AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Purple Biotech Ltd. Capital/Financing Update 2017

Nov 1, 2017

7004_rns_2017-11-01_ae4c5703-ef81-48dc-9660-8da456af19ab.htm

Capital/Financing Update

Opens in your device viewer

_________ false


�� "�	2 352
KITOV PHARMACEUTICALS HOLDINGS LTD
Corporation no: 520031238	10994
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C004 ( Public )		Reported via MAGNA:	01/11/2017
	www.isa.gov.il			www.tase.co.il				Reference:	2017-02-096067	Time of broadcast: 22:44 22:41:20

Immediate report on other matterDon't use this form if there is more adequate one


UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM D Notice of Exempt Offering of Securities KITOV PHARMACEUTICALS HOLDINGS LTD. �� "��" �� "�. �� , �� , �� , ��
Attached file fd1017_kitovpharmaEDGAR3_isa.pdf


The submission by the Company to the Israel Securities Authority and the Tel Aviv Stock Exchange of a copy of a Form D originally submitted by the Company to the United States Securities Exchange Commission for the purposes of notifying the United States Securities Exchange Commission, as well for purposes of notifying the applicable State(s) of solicitation, of an exempt offering of securities in the United States of America and within such applicable State(s) of solicitation, should not be deemed an admission by the Company that such submission is required of the Company under the Securities Law 5728-1968 and the Securities Regulations (Periodic and Immediate Reports of Foreign Corporation) 5761-2000, nor an admission by the Company that this submission is necessarily being delivered pursuant to the aforesaid laws and regulations.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 25/09/2017
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: [email protected] Company site: www.kitovpharma.com

Previous names of reporting entity: MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,

Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: [email protected] 1
Israel